Express Pharma

JANUARY 13, 2025

This potential was acknowledged by the pharmaceutical industry professionals in a survey* conducted by GlobalData. In the same survey, pharmaceutical industry professionals identified lead generation and optimisation in drug discovery as the area in which AI has been most effectively integrated so far.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Express Pharma

DECEMBER 16, 2024

On December 13, 2024, Lupin, a global pharmaceutical company, announced the acquisition of anti-diabetes trademarks GIBTULIO, GIBTULIO MET, and AJADUO from Boehringer Ingelheim International GmbH. The trademark rights for these brands are set to be transferred to Lupin by March 2025.

Diabetes 105

Diabetes Pharmaceutical Companies Pharmaceutical Companies 105

Express Pharma

FEBRUARY 9, 2025

In October 2024, the programme entered a strategic commercial partnership with Sun Pharma, a leading multinational pharmaceutical company. Key study readouts for Phase III FIBROSARC and Phase II FLASH are expected between March and June 2025. The study is expected to complete enrollment between Q4 2025 and Q1 2026.

Pharmaceutical Companies 66

Pharmaceutical Companies Pharmaceutical Companies 66

Express Pharma

FEBRUARY 9, 2025

Alkem Laboratories, an Indian pharmaceutical company, has announced two strategic acquisitions aimed at strengthening its position in the domestic market. The company has signed a binding term sheet to acquire a 100 per cent stake in Adroit Biomed, a company focused on the skincare segment, for approximately INR 140 crore.

Pharmaceutical Companies 66

Pharmaceutical Companies Pharmaceutical Companies 66

Express Pharma

DECEMBER 30, 2024

They also discussed the increasing global emphasis on traceability and the tracking of recall effectiveness, which would require pharmaceutical companies to have detailed documentation of all affected products and batches. The post FOPE & PharmaState Academy host Session 12 of the PULSE series appeared first on Express Pharma.

Documentation 105

Documentation Communication Packaging Pharmaceutical Companies 105

Express Pharma

MARCH 16, 2025

In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Indian pharmaceutical companies have specialised in reverse-engineering complex medicines and producing biosimilars as alternatives to costly biologics.

Biosimilars 98

Biosimilars Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies 98

Express Pharma

JANUARY 22, 2025

The award was presented during a ceremony at Hotel Ritz Carlton, Pune, on January 21, 2025, in the presence of Chief Guest Dr R A Mashelkar, a scientist and Padma Vibhushan awardee. This groundbreaking research will take place within the Bio Cluster, with support from several leading pharmaceutical companies.”

Vaccines 109

Vaccines Pharmaceutical Companies Pharmaceutical Companies 109

Pharma Marketing Network

OCTOBER 17, 2024

In an increasingly competitive pharmaceutical landscape, the significance of healthcare branding has never been more pronounced. As we approach 2025, the ability of pharmaceutical companies to effectively craft and communicate their brand identity will play a pivotal role in determining their market success.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Express Pharma

FEBRUARY 17, 2025

Generative AI (GenAI) is being integrated into India’s pharmaceutical and healthcare sectors, according to EYs report, How much productivity can GenAI unlock in India? The AIdea of India: 2025. GenAI is being applied to multiple functions in pharmaceutical companies.

Documentation 71

Documentation Customer Service Pharmaceutical Companies Pharmaceutical Companies 71

Express Pharma

JANUARY 24, 2025

In a notification issued earlier this month, The Union Health Ministry has granted a one-year extension to small and medium-sized pharmaceutical companies to upgrade their facilities as per the revised Schedule M of the Drugs and Cosmetic Act.

Communication 99

Communication Pharmaceutical Companies Pharmaceutical Companies 99

European Pharmaceutical Review

FEBRUARY 13, 2025

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Marketing Network

JANUARY 7, 2025

In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. Digital Dominance in Pharma Marketing The digital revolution has officially taken over the pharmaceutical industry, and theres no turning back. What are the biggest challenges in pharma marketing in 2025?

HIPAA 52

HIPAA Communication Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JUNE 10, 2024

The company hopes to produce this number tenfold by the end of 2030. Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis. In January 2024, the pharmaceutical company obtained manufacturing authorisation for its largest radioligand therapy facility.

Pharmaceutical Manufacturing 98

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

NOVEMBER 1, 2024

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 As pharmaceutical companies are making investments in sustainable packaging this is also driving demand in this market, based on analysis of the study’s findings.

Packaging 52

Packaging Dosage Labelling Pharmaceutical Companies 52

Pharma Marketing Network

OCTOBER 17, 2024

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. With the increasing digitization of healthcare, pharmaceutical companies are leveraging digital platforms to reach broader audiences more effectively.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Scheduling Appointments 52

FDA Law Blog: Biosimilars

MARCH 18, 2025

On March 13, 2025, the Federal Circuit ventured into the world of reissued patents and PTE. ( Specifically, the Court focused on the purpose: to compensate pharmaceutical companies for the effective truncation of their patent terms while waiting for regulatory approval of new drug applications. In Merck Sharp & Dohme Corp.

Drug Pricing 59

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

MARCH 27, 2025

As scientific and pharmaceutical companies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. 1 Figure 1 : Costs for UK skilled worker visa compared to those of other leading science nations.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling 52

European Pharmaceutical Review

FEBRUARY 27, 2024

At the time of the announcement, the pharmaceutical company shared that the first Stelara biosimilars are expected to enter the US market in 2025. The post Amgen opens its most advanced manufacturing facility to date appeared first on European Pharmaceutical Review.

Biosimilars 105

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

Pharmaceutical Technology

JUNE 7, 2023

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Labelling Diabetes 98

European Pharmaceutical Review

OCTOBER 6, 2023

There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company. The company reported that a Phase III trial of mRNA-1083 for adults 50 years old and over is set to begin in 2023.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

AUGUST 1, 2022

The DDiCT initiative aligns with the pharmaceutical company’s broader diversity and inclusion goals for 2020-2025, which aim to address health disparities, clinical trial diversity, supplier diversity, employee giving and workforce representation. Efforts to improve clinical trial diversity are ongoing.

Drug Development 122

Drug Development Pharmaceutical Companies Pharmaceutical Companies 122

Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Health for Humanity 2025 Goals.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

Pharma Mirror

SEPTEMBER 8, 2021

Marseille, France, Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, today announces a €120 million ($142.3M) strategic funding. This includes. The post Provepharm Life Solutions raises €120 million appeared first on Pharma Mirror Magazine.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Business Review

OCTOBER 22, 2024

This latest agreement took Samsung Biologics’ accumulated contracts for this year to over $3.3bn, the company noted. Samsung Biologics president and CEO John Rim said: “We are pleased to strategically collaborate with the Asia-based pharmaceutical company to bring effective, high-quality biopharmaceuticals to the global market.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 18, 2021

8 It’s encouraging to see this as one of the goals in the EMA’s 2025 Regulatory Sciences Strategy. What remains very clear is that collaboration between sponsor companies, health authorities and other stakeholders will be required to move this forward. Real-time sharing of data.

Vaccines 143

Vaccines Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 143

Express Pharma

OCTOBER 16, 2024

Manufacturing costs in India are also 30 – 35 per cent lower than those in the US and Europe (5), further sweetening the deal for global pharmaceutical companies. However, understanding the complex global regulatory environment is essential for Indian CROs, CMOs, and CDMOs to take full advantage of these opportunities.

Biosimilars 103

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 103

European Pharmaceutical Review

DECEMBER 18, 2024

percent (high dose), the pharmaceutical companies reported. Detailed findings of this study are set to be presented at a scientific forum in 2025, according to Sanofi and Teva. For patients with Crohns disease, at week 14, 26.1 percent (low-dose) and 47.8 percent on placebo, 13.0 percent (low dose) and 34.8

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

PharmaState Academy

DECEMBER 18, 2024

This quiz competition is brought to you by Now & Next Summit on Pharma Marketing | Edition 2 scheduled for 18th Jan 2025 at Jio World Convention Centre, BKC, Mumbai. a) At least 3 b) At least 5 c) At least 10 d) At least 15 5 / 20 What percentage of HCPs find scientific information provided by pharma companies useful in their practice?

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

SEPTEMBER 22, 2022

The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. GlobalData is the parent company of Pharmaceutical Technology.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Dosage 52

Pharmaceutical Technology

MAY 23, 2023

The recent legislative reform proposals put forward by the European Commission (EC) have sparked significant discontent among pharmaceutical companies. This blog explores the key areas of concern for pharmaceutical companies and some of the potential implications of these reforms.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Biosimilars Packaging 52

Pharmaceutical Technology

OCTOBER 31, 2022

Two categories of novel therapies stand out: cell therapies and therapies with novel MOAs, with new products in each category being forecast to launch between 2023 and 2025. The OA space has long been dominated by large pharmaceutical companies such as Bayer, Pfizer, and Eli Lilly. of the 7MM sales, respectively.

Compounding 59

Compounding Pharmaceutical Companies Pharmaceutical Companies 59

The Thyroid Pharmacist

NOVEMBER 29, 2023

The truth is that most supplement companies do not undergo the same scrutiny and testing that pharmaceutical products do, because many of the tests which are required of pharmaceutical companies are voluntary for supplement companies. We have 270 expiring in March 2025.) We have 299 expiring in March 2025.)

Health and Personal Care Stores 73

Health and Personal Care Stores Immunity Immunization Labelling 73

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

OCTOBER 13, 2022

However, patent protection remains in some major markets, including France, Italy, Spain, and the UK until 2025. The question is whether other major pharmaceutical companies will be attracted to the space – particularly when areas such as oncology and orphan drugs currently provide a larger return on investment.

Biosimilars 98

Biosimilars Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

MAY 10, 2022

Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC), talks about how the healthcare industry needs to come together to reduce its environmental impact and further protect public health. About the author.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

pharmaphorum

MARCH 12, 2021

Behind all of these are massive and growing volumes of data that life sciences companies generate, manage and analyse to secure breakthroughs. One estimate [1] suggests that by 2025 more than 60 million patients will have their genome sequenced. And those volumes will only increase.

Vaccines 111

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 111

pharmaphorum

JULY 1, 2021

My SynBioBeta panel discussion was about the shape of biopharma in 2025 – a seemingly futuristic time that’s now less than four years away. Tanja Dowe is the CEO of Debiopharm Innovation Fund, the strategic investment arm of the Swiss pharmaceutical company Debiopharm. About the interviewee.

Drug Development 88

Drug Development Pharmaceutical Companies Pharmaceutical Companies Vaccines 88